Fund moves

Globus Medical (GMED): Segall Bryant & Hamill, LLC added to its stake +14K shares

Segall Bryant & Hamill, LLC added to its stake in Globus Medical, per its Q3 2025 13F.

482K
Shares reported · +14K vs prior quarter
0.37%
Disclosed portfolio weight
$27.6M
Reported value
Holdings as of
Sep 30, 2025
Filed
Nov 12, 2025

What stands out in this filing

  • 468,053 shares in Q2 2025, 481,636 now (+2.9% in share count).
  • Reported at $27.6M, 0.37% of the portfolio value in this 13F filing.
  • 9 other tracked managers reported the same kind of change for Q3 2025.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 15, 2025InsiderDirector sold ~$585K of GMED shares in the open market
  2. Oct 16, 2025Federal contract · $25K obligatedDepartment of Defense awarded GLOBUS MEDICAL INC: $25K obligated to date
  3. Nov 6, 2025Company filing · Form 8-K · ResultsReported its results
  4. Nov 7, 2025InsiderDirector sold ~$648K of GMED shares in the open market
  5. Nov 10, 2025InsiderDirector sold ~$170K of GMED shares in the open market
  6. Nov 11, 2025InsiderDirector sold ~$2.11M of GMED shares in the open market
  7. Nov 12, 2025InsiderDirector sold ~$2.15M of GMED shares in the open market

What came next

  1. Nov 25, 2025InsiderOfficer sold ~$675K of GMED shares in the open market
  2. Dec 12, 2025InsiderDirector sold ~$355K of GMED shares in the open market
  3. Jan 7, 2026Company filing · Form 8-K · ResultsReported its results
  4. Jan 8, 2026Insider · 2 peopleInsiders: 2 sales (~$566K)
  5. Jan 13, 2026Federal contract · $42K obligatedDepartment of Defense awarded GLOBUS MEDICAL INC: $42K obligated to date
  6. Jan 15, 2026Federal contract · $61K obligatedDepartment of Defense awarded GLOBUS MEDICAL INC: $61K obligated to date
  7. Jan 22, 2026Federal contract · $27K obligatedDepartment of Defense awarded GLOBUS MEDICAL INC: $27K obligated to date
  8. Jan 28, 2026Federal contract · $31K obligatedDepartment of Defense awarded GLOBUS MEDICAL INC: $31K obligated to date
  9. Feb 12, 2026InsiderOfficer sold ~$877K of GMED shares in the open market
  10. Feb 20, 2026Federal contract · $64K obligatedDepartment of Defense awarded GLOBUS MEDICAL INC: $64K obligated to date
  11. Feb 24, 2026Company filing · Form 8-K · ResultsReported its results
  12. Feb 25, 2026Insider · Their largest sale since 2019Officer sold ~$1.89M of GMED shares in the open market
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Globus Medical

For Globus Medical, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its GMED page.

How this filing works

Explore the data

Common questions

What does this filing report about Globus Medical (GMED) stock?

Segall Bryant & Hamill, LLC added to its stake in Globus Medical, per its Q3 2025 13F. Now 482K shares, $27.6M reported value, 0.37% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Sep 30, 2025. Filed: Nov 12, 2025.

What stands out in this filing?

468,053 shares in Q2 2025, 481,636 now (+2.9% in share count). Reported at $27.6M, 0.37% of the portfolio value in this 13F filing. 9 other tracked managers reported the same kind of change for Q3 2025.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Globus Medical recently?

For Globus Medical, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the GMED page.

Does this mean GMED stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Globus Medical

Everything OQRO holds on this company is on its GMED page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data